We are live on ! Find out more
GAA

Green Alpha Advisors Portfolio holdings

AUM $149M
1-Year Est. Return 118.1%
This Fund
S&P 500
This Quarter Est. Return
+65.5%
1 Year Est. Return
+118.1%
3 Year Est. Return
+267.27%
5 Year Est. Return
+298.06%
10 Year Est. Return
AUM
$149M
AUM Growth
+$47.5M
Cap. Flow
+$1.31M
Cap. Flow %
0.88%
Top 10 Hldgs %
42.29%
Holding
113
New
6
Increased
40
Reduced
67
Closed

Top Buys

Rank Stock Value
1
NXTE icon
AXS Green Alpha ETF
NXTE
+$2.44M
2
BEAM icon
Beam Therapeutics
BEAM
+$229K
3
YETI icon
Yeti Holdings
YETI
+$227K
4
TXG icon
10x Genomics
TXG
+$219K
5
AZTA icon
Azenta
AZTA
+$199K

Sector Composition

Rank Sector Weight
1 Technology 62.33%
2 Healthcare 12.52%
3 Industrials 7.73%
4 Consumer Discretionary 4.56%
5 Utilities 4.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZS icon
76
Zscaler
ZS
$29.8B
$398K 0.27%
2,817
+84
+3% +$11.7K
GH icon
77
Guardant Health
GH
$21.7B
$385K 0.26%
2,569
-1
-0% -$109
CWT icon
78
California Water Service
CWT
$3.12B
$381K 0.26%
7,830
-13
-0.2% -$586
JOBY icon
79
Joby Aviation
JOBY
$6.9B
$371K 0.25%
41,568
+568
+1% +$5.49K
BETA
80
Beta Technologies Inc
BETA
$4.72B
$358K 0.24%
21,346
+274
+1% +$4.56K
GRAL
81
GRAIL Inc
GRAL
$3.57B
$355K 0.24%
5,194
+2
+0% +$118
PD icon
82
PagerDuty
PD
$1.09B
$348K 0.23%
36,014
+134
+0.4% +$1.01K
TXG icon
83
10x Genomics
TXG
$8.02B
$321K 0.22%
+8,372
New +$219K
PATH icon
84
UiPath
PATH
$9.4B
$312K 0.21%
28,745
+168
+0.6% +$1.79K
PACB icon
85
Pacific Biosciences
PACB
$435M
$300K 0.2%
178,655
-3,963
-2% -$5.76K
PONY
86
Pony AI Inc
PONY
$3.29B
$288K 0.19%
41,484
+313
+0.8% +$2.9K
DUOL icon
87
Duolingo
DUOL
$6.88B
$287K 0.19%
2,491
+37
+2% +$4.05K
PRMB
88
Primo Brands
PRMB
$8.32B
$280K 0.19%
11,463
-102
-0.9% -$2.26K
VRTX icon
89
Vertex Pharmaceuticals
VRTX
$137B
$274K 0.18%
552
+6
+1% +$2.66K
BEAM icon
90
Beam Therapeutics
BEAM
$3.03B
$260K 0.17%
+7,569
New +$229K
YETI icon
91
Yeti Holdings
YETI
$3.03B
$260K 0.17%
+5,240
New +$227K
SLP icon
92
Simulations Plus
SLP
$372M
$249K 0.17%
13,606
-100
-0.7% -$1.54K
SOPH icon
93
SOPHiA GENETICS
SOPH
$693M
$247K 0.17%
42,765
-187
-0.4% -$949
CSTL icon
94
Castle Biosciences
CSTL
$1.02B
$237K 0.16%
9,941
-4
-0% -$89
NTLA icon
95
Intellia Therapeutics
NTLA
$1.8B
$235K 0.16%
13,886
-281
-2% -$3.93K
TEAM icon
96
Atlassian
TEAM
$48.2B
$232K 0.16%
2,987
+37
+1% +$3.03K
AWK icon
97
American Water Works
AWK
$27.5B
$230K 0.15%
1,745
+54
+3% +$6.94K
SNPS icon
98
Synopsys
SNPS
$84.8B
$228K 0.15%
512
-2
-0.4% -$940
AZTA icon
99
Azenta
AZTA
$1.44B
$226K 0.15%
+8,874
New +$199K
RELY icon
100
Remitly
RELY
$5.62B
$223K 0.15%
9,950
-187
-2% -$3.83K

Similar funds

Green Alpha Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, Green Alpha Advisors held 113 positions worth $149M, up 47% from $102M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Green Alpha Advisors's Q2 2026 filing shows 6 new, 40 increased and 67 reduced positions. Its largest new stake was Beam Therapeutics: 7,569 shares worth $260K. The largest sale was Horizon Technology Finance, an estimated $693K.

By sector, the portfolio is most concentrated in Technology at 62% of assets, up from 56% a quarter earlier, followed by Healthcare and Industrials.

  • Green Alpha Advisors's largest Q2 2026 buy was Beam Therapeutics: 7,569 shares worth $260K.
  • Green Alpha Advisors added most to AXS Green Alpha ETF in Q2 2026, an estimated $2.44M increase.
  • Green Alpha Advisors's biggest Q2 2026 reduction was Horizon Technology Finance, cutting an estimated $693K.
  • Green Alpha Advisors's ten largest holdings make up 42% of its $149M portfolio in Q2 2026.
  • Green Alpha Advisors opened 6 new positions and closed 0 in Q2 2026.
  • Green Alpha Advisors's portfolio value rose 47% quarter-over-quarter to $149M.

Based on Green Alpha Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.